# Report: 5_AC_neuronal_like (run_1.md)

**Cell type:** glioblastoma cells
**Disease:** malignant glioblastoma (WHO grade IV)
**Tissue:** brain

## Program Summaries
### Immune Checkpoint Signaling
A gene program mediating immune escape through checkpoint molecule expression and T-cell exhaustion pathways. CD96 functions as an immune checkpoint regulating CD8+ T-cell antitumor function. STAT4 regulates PD-L1 expression and immune evasion. CD163 and MSR1 mark pro-tumoral macrophage populations. OLR1 associates with immune cell infiltration and immunosuppression. TLR2 initiates pathogen recognition signaling in innate immune cells. This program collectively enables glioblastoma immune evasion via checkpoint activation and immunosuppressive microenvironment establishment.

**Predicted impacts:**
- Enhanced CD8+ T-cell exhaustion and reduced anti-tumor immunity
- Increased PD-L1 expression on tumor cells and immune cells
- Macrophage skewing toward pro-tumoral M2 phenotype
- Reduced interferon-gamma production and T-cell activation
- Increased IL-10 and TGF-β secretion

**Supporting genes:** CD96, STAT4, CD163, MSR1, OLR1, TLR2

**References:** [31], [42], [49], [54]

**Biological processes:**
- CD8+ T-cell exhaustion and anergy: CD96, STAT4
- PD-L1 transcriptional regulation: STAT4, CD96
- Macrophage-mediated immunosuppression: CD163, MSR1, OLR1
- Toll-like receptor signaling: TLR2

**Reference notes:**
- CD96 immune checkpoint regulates CD8+ T-cell function and metastasis
- MET-STAT4-PD-L1 axis in glioma immune evasion
- CD163 and Iba1 in TAM-mediated glioma progression
- MSR1 in immune regulation and macrophage phenotype

### Receptor Tyrosine Kinase Signaling
A gene program comprising components of receptor tyrosine kinase (RTK) signaling pathways that drive glioblastoma proliferation, survival, and invasion. TEK (Tie2) mediates angiopoietin signaling and vessel maturation. DOCK2, DOCK8, and downstream SYK coordinate Rho GTPase activation for cytoskeletal reorganization. WIPF1 facilitates FAK-mediated actin polymerization. This program collectively enhances receptor-mediated signaling critical for glioblastoma growth and angiogenesis.

**Predicted impacts:**
- Enhanced angiogenic signaling through Tie2 activation
- Increased Rac and Cdc42 GTPase activity driving cell migration
- Enhanced focal adhesion signaling and invasive capacity
- Elevated MAPK and PI3K/AKT pathway activation
- Increased cytoskeletal remodeling and invadopodia formation

**Supporting genes:** TEK, DOCK2, DOCK8, SYK, WIPF1

**References:** [21], [55], [7]

**Biological processes:**
- Angiopoietin-Tie2 signaling: TEK
- DOCK-mediated Rho GTPase activation: DOCK2, DOCK8
- Spleen tyrosine kinase (SYK) signaling: SYK
- Actin polymerization and cytoskeletal dynamics: WIPF1

**Cellular components:**
- Cell membrane receptor complexes: TEK, DOCK2, DOCK8

**Reference notes:**
- RTK/Ras/PI3K pathway altered in 86-90% of GBM; critical for GBM pathogenesis
- DOCK8 mutation impairs B-cell and T-cell immune responses relevant to glioma microenvironment
- TRPV4/Cdc42/N-wasp signaling axis regulates invasion-growth in glioblastoma

### Synaptic Adhesion and Neuronal Communication
A gene program mediating cell-cell adhesion at synapses and neuron-neuron interactions through adhesion molecules and signaling proteins. CNTNAP2 is essential for synaptic function and neuronal migration; loss impairs E/I balance and cortical development. IL1RAPL1 is a synaptic adhesion molecule recruiting PTPδ and inducing excitatory synapse formation. NLGN4X encodes neuroligin-4, crucial for synaptic organization and neurotransmission. PCDH7 and PCDH11X are protocadherins involved in cell-cell recognition. SYT1 and SYN3 mediate neurotransmitter release and synaptic plasticity. This program regulates the synaptic connectivity landscape that glioma cells aberrantly reactivate.

**Predicted impacts:**
- Aberrant reactivation of synaptic adhesion programs in glioma cells
- Enhanced intercellular communication and adhesion between tumor cells
- Altered calcium signaling through synaptic-like connections
- Increased neurotransmitter-like signaling in tumor microenvironment
- Formation of tumor cell-neuron hybrid synaptic structures

**Supporting genes:** CNTNAP2, IL1RAPL1, NLGN4X, PCDH7, PCDH11X, SYT1, SYN3, SLIT2, RELN, CHRNA7

**References:** [12], [13], [17], [38]

**Biological processes:**
- Synaptic adhesion molecule expression: CNTNAP2, IL1RAPL1, NLGN4X, PCDH7, PCDH11X
- Neurotransmitter release and synaptic transmission: SYT1, SYN3, CNTNAP2
- Neuronal migration and axon guidance: CNTNAP2, SLIT2, RELN

**Cellular components:**
- Synaptic membrane proteins: SYT1, SYN3, CNTNAP2, IL1RAPL1, NLGN4X
- Extracellular matrix anchoring proteins: SLIT2, RELN

**Reference notes:**
- CNTNAP2 deficiency in ASD and neurodevelopmental disorders; role in E/I balance
- IL1RAPL1 synaptic adhesion and postsynaptic density formation
- NLGN4X mutations in autism; synaptic organization and neurotransmission
- IGSF3 interaction with Kir4.1 and glioma-related epileptiform activity

### Ion Channel Dysregulation and Excitotoxicity
A gene program mediating alterations in ion channel expression and calcium homeostasis that promote glioma proliferation and seizure activity. TRPV4 elevates intracellular calcium and promotes invadopodia formation via Cdc42/N-wasp signaling. TRPM8 and TRPM3 modulate calcium and cation fluxes. KCNH7, KCNIP4, RYR2, and RYR3 regulate potassium and ryanodine-sensitive calcium channels. GRIN2B encodes NMDA receptor subunit 2B, contributing to glutamate-mediated calcium signaling. FXYD5 regulates Na+/K+-ATPase. This program collectively dysregulates ion homeostasis, promoting both tumor progression and neuronal hyperexcitability manifesting as glioma-related epilepsy.

**Predicted impacts:**
- Increased intracellular free calcium concentration
- Enhanced invadopodia formation and invasion capacity
- Dysregulated potassium buffering and loss of ion homeostasis
- Amplified glutamate-mediated excitatory signaling
- Glioma-related seizures and epileptiform activity
- Metabolic reprogramming via calcium-dependent kinases

**Supporting genes:** TRPV4, TRPM8, TRPM3, KCNH7, KCNIP4, RYR2, RYR3, GRIN2B, FXYD5

**References:** [11], [21], [38], [8]

**Biological processes:**
- Calcium influx and intracellular calcium elevation: TRPV4, TRPM8, TRPM3, RYR2, RYR3, GRIN2B
- Potassium channel dysregulation and ion imbalance: KCNH7, KCNIP4, FXYD5
- Glutamate-mediated excitotoxicity: GRIN2B

**Cellular components:**
- Calcium-activated signaling complexes: TRPV4, TRPM8, RYR2, GRIN2B

**Reference notes:**
- TRPV4 elevated in malignant glioma; TRPV4/Cdc42/N-wasp axis regulates invasion and invadopodia formation
- IGSF3-Kir4.1 interaction impairs potassium buffering; dysregulation linked to glioma proliferation and seizures
- Glutamate-calcium signaling provides positive feedback for glioma progression
- Calcium channel alterations in glioblastoma stem cells and glioma tissue

### Extracellular Matrix Remodeling and Invasion
A gene program controlling extracellular matrix (ECM) degradation, remodeling, and production that facilitates glioma invasion and infiltration into normal brain parenchyma. ADAMTS3, ADAMTS14, and ADAMTS18 are metalloproteases cleaving lecticans and other ECM components. POSTN (periostin) is upregulated in cancer-associated fibroblasts and promotes ECM remodeling and invasion. SULF1 modifies heparan sulfate proteoglycans. COL4A6, COL12A1, COL19A1 are collagen scaffolds. SMOC2 and other matricellular proteins regulate cell-matrix interactions. This program collectively restructures the brain microenvironment to enable glioma cell dissemination.

**Predicted impacts:**
- Enhanced ECM degradation and proteolytic remodeling
- Increased invasive capacity into surrounding brain parenchyma
- Altered collagen fiber alignment facilitating migration
- Enhanced cell-matrix interactions promoting dissemination
- Reduced ECM mechanical impedance to tumor infiltration

**Supporting genes:** ADAMTS3, ADAMTS14, ADAMTS18, POSTN, SULF1, COL4A6, COL12A1, COL19A1, SMOC2

**References:** [15], [18], [32]

**Biological processes:**
- Lectin cleavage and ECM degradation: ADAMTS3, ADAMTS14, ADAMTS18
- Periostin-mediated matrix remodeling: POSTN
- Heparan sulfate proteoglycan modification: SULF1
- Collagen fiber organization: COL4A6, COL12A1, COL19A1

**Cellular components:**
- Extracellular matrix scaffold: POSTN, ADAMTS3, COL4A6, COL12A1, SMOC2

**Reference notes:**
- ADAMTS-mediated BEHAB/brevican cleavage necessary for glioma invasion
- POSTN upregulation in cancer-associated fibroblasts; promotes ECM remodeling and invasion
- ECM composition and organization profoundly influence glioma invasion patterns

### Angiogenesis and Vascular Development
A gene program regulating blood vessel formation and vascular endothelial cell function that supports glioma growth. VEGFD (VEGF-D) is secreted by tumor cells and activates VEGFR-2 and VEGFR-3 on endothelial cells. TEK (Tie2) mediates angiopoietin signaling for vessel maturation and stabilization. KLF5 promotes glioblastoma angiogenesis by inducing AGGF1 gene transcription in glioma-associated endothelial cells. This program collectively drives pathological neovascularization that perfuses the tumor and enables growth beyond diffusion limits.

**Predicted impacts:**
- Increased endothelial cell proliferation and vascular sprouting
- Enhanced vascular permeability and blood-brain barrier dysfunction
- Vessel stabilization and reduced hemorrhagic necrosis
- Increased oxygen and nutrient delivery to tumor
- Promotion of glioma cell intravasation and dissemination

**Supporting genes:** VEGFD, TEK, KLF5

**References:** [19], [45], [50]

**Biological processes:**
- VEGF-D signaling and vascular proliferation: VEGFD
- Tie2-angiopoietin vascular stabilization: TEK
- KLF5-mediated angiogenic factor expression: KLF5

**Cellular components:**
- Vascular endothelial cell surface receptors: VEGFD, TEK

**Reference notes:**
- VEGF-D role in glioblastoma angiogenesis and resistance to anti-VEGF therapy
- Angiopoietin-Tie2 signaling in glioma vessel maturation
- KLF5 promotes glioblastoma angiogenesis via AGGF1

### Wnt/β-Catenin Self-Renewal Signaling
A gene program mediating Wnt signaling pathway activation that promotes glioma stem cell self-renewal and inhibits differentiation. WNT16 is a Wnt ligand activating canonical β-catenin signaling. This program drives stemness maintenance and chemotherapy resistance characteristic of glioblastoma stem cells (GSCs), which are responsible for tumor recurrence.

**Predicted impacts:**
- Increased glioma stem cell self-renewal capacity
- Enhanced resistance to differentiation signals
- Improved tumor growth and propagation
- Enhanced chemotherapy and radiotherapy resistance
- Tumor recurrence and regrowth after standard therapy

**Supporting genes:** WNT16

**References:** [27], [30]

**Biological processes:**
- Canonical Wnt/β-catenin pathway activation: WNT16
- Stemness maintenance and self-renewal: WNT16

**Reference notes:**
- WNT signaling roles in GSC self-renewal and glioma progression
- Wnt/β-catenin pathway dysregulation in glioblastoma; correlation with WHO grade and poor prognosis

### Epithelial-Mesenchymal Transition and Invasion
A gene program regulating epithelial-mesenchymal transition (EMT) that enables glioma cell migration, invasion, and dissemination. EMT transcription factors (TWIST-family, SNAIL-family, ZEB-family, SOX2) promote acquisition of mesenchymal phenotype and down-regulation of epithelial markers. TGM2 (tissue transglutaminase) is upregulated during EMT and promotes invasion. POSTN supports EMT through CAF interactions. This program collectively drives the phenotypic plasticity enabling glioma cells to invade adjacent brain tissue and metastasize.

**Predicted impacts:**
- Increased cell motility and migration capacity
- Enhanced invasive capability into surrounding brain parenchyma
- Reduced intercellular adhesion and increased dissemination
- Acquisition of stem cell-like properties
- Increased resistance to chemotherapy and radiotherapy

**Supporting genes:** TGM2, POSTN

**References:** [32], [56], [59]

**Biological processes:**
- EMT transcription factor activation: TGM2
- E-cadherin to N-cadherin switch: TGM2
- Vimentin upregulation and EMT markers: TGM2

**Cellular components:**
- Adherens junction remodeling: TGM2, POSTN

**Reference notes:**
- EMT and E-cadherin/N-cadherin switching in glioblastoma invasion
- EMT transcription factors and stemness maintenance in glioma
- POSTN promotes EMT and invasion in gastric cancer; relevant to glioma microenvironment

### Hypoxia-Responsive Transcription
A gene program activated under hypoxic conditions (low oxygen) in glioblastoma that drives metabolic reprogramming, angiogenesis, and stemness maintenance. This program includes HIF-1α and HIF-2α-dependent transcriptional responses, though HIFs themselves are not in the input list. VEGFD, TEK, and KLF5 are key HIF-target genes promoting angiogenesis. Downstream metabolic enzymes (ME1 for gluconeogenesis; SUCLG2 for TCA cycle) support hypoxic metabolism. This program collectively enables tumor survival and growth in the hypoxic glioblastoma microenvironment.

**Predicted impacts:**
- Enhanced survival under hypoxic stress
- Increased VEGF production and angiogenesis
- Metabolic shift toward glycolysis and amino acid metabolism
- Enhanced glioma stem cell self-renewal
- Resistance to hypoxia-induced apoptosis

**Supporting genes:** VEGFD, TEK, KLF5, ME1, SUCLG2

**References:** [57], [60]

**Biological processes:**
- Angiogenic factor upregulation: VEGFD, TEK, KLF5
- Metabolic reprogramming and glycolysis: ME1, SUCLG2
- Cancer stem cell maintenance: VEGFD, KLF5

**Reference notes:**
- Hypoxia-induced HIF signaling in glioblastoma; metabolic reprogramming and GSC maintenance
- HIF-1α and HIF-2α in stemness and metabolic adaptation in glioblastoma

### Lipid Metabolism and Signaling
A gene program regulating lipid metabolism, storage, and signaling that supports glioblastoma proliferation and stemness. PLD1 (phospholipase D1) catalyzes phosphatidic acid production, acting as both an enzymatic catalyst and scaffolding protein in Wnt/β-catenin, PI3K/Akt, and HIF signaling. OLR1 (LOX-1) is a scavenger receptor mediating oxidized lipid uptake and promoting EMT and stemness. ACER2 (alkaline ceramidase 2) regulates ceramide metabolism. This program collectively integrates lipid signaling into core oncogenic pathways.

**Predicted impacts:**
- Enhanced PI3K/Akt and mTOR signaling
- Increased Wnt/β-catenin pathway activation
- Enhanced stemness and self-renewal capacity
- Improved metabolic flexibility under diverse nutrient conditions
- Reduced immune cell infiltration and T-cell activation

**Supporting genes:** PLD1, OLR1, ACER2

**References:** [20], [25]

**Biological processes:**
- Phospholipase D signaling: PLD1
- Oxidized lipid uptake and scavenging: OLR1
- Cancer stem cell self-renewal via lipid signaling: PLD1, OLR1

**Cellular components:**
- Plasma membrane lipid microdomains: PLD1, OLR1

**Reference notes:**
- PLD1 as key player in cancer stemness and Wnt/PI3K cross-talk
- OLR1 in cancer immune escape and EMT

### Tumor-Associated Macrophage Polarization
A gene program regulating polarization and activation of tumor-associated macrophages (TAMs) that create an immunosuppressive microenvironment. CD163 identifies M2-like pro-tumor macrophages enriched in glioblastoma. MSR1 (CD204) is a macrophage-specific receptor involved in pro-inflammatory phenotype. OLR1 is overexpressed in myeloid-derived suppressor cells (MDSCs) and promotes immunosuppression. LCP2 and FYB1 facilitate leukocyte signaling. VSIG4 is an immunosuppressive receptor on macrophages. This program collectively recruits and polarizes TAMs toward anti-tumor immunity suppression.

**Predicted impacts:**
- Increased macrophage infiltration into glioblastoma
- Polarization toward pro-tumor M2 phenotype
- Enhanced IL-10 and TGF-β secretion
- Reduced CD8+ T-cell activation and infiltration
- Increased glioma stem cell maintenance via IL-33

**Supporting genes:** CD163, MSR1, OLR1, LCP2, FYB1, VSIG4

**References:** [25], [31], [34], [49]

**Biological processes:**
- M2 macrophage polarization: CD163, MSR1
- Immunosuppressive cell recruitment: OLR1, LCP2
- Leukocyte adhesion and migration: LCP2, FYB1
- Immunosuppressive checkpoint signaling: VSIG4

**Cellular components:**
- Macrophage surface receptors: CD163, MSR1, OLR1, VSIG4

**Reference notes:**
- CD163, Iba1, and IL-33 in TAM-mediated glioma progression
- TAM polarization and CCL8 secretion in glioma immune evasion
- OLR1 in immunosuppressive cell infiltration
- MSR1 in macrophage-mediated immune regulation

### GTPase Activation and Cytoskeletal Remodeling
A gene program regulating small GTPase (Rho, Rac, Cdc42) activation and actin cytoskeleton reorganization that enables glioma cell migration and invasion. DOCK2 and DOCK8 are guanine nucleotide exchange factors (GEFs) that activate Rac (DOCK2) and Cdc42 (DOCK8). Downstream effectors (N-WASP, WAVE) nucleate actin filaments. WIPF1 facilitates FAK-Rac coupling. STAC and RCAN2 coordinate Cdc42 and calcium signaling. This program collectively enables rapid morphological changes and invasion-promoting cellular protrusions.

**Predicted impacts:**
- Enhanced Rac1 activation and lamellipodia formation
- Enhanced Cdc42 activation and filopodia formation
- Increased actin polymerization and cytoskeletal reorganization
- Enhanced cell migration velocity and invasiveness
- Increased invadopodia formation for ECM degradation

**Supporting genes:** DOCK2, DOCK8, WIPF1, STAC, RCAN2, TRPV4

**References:** [10], [21]

**Biological processes:**
- Rac1 GTPase activation: DOCK2
- Cdc42 GTPase activation: DOCK8, TRPV4
- Actin filament nucleation and polymerization: WIPF1

**Cellular components:**
- Guanine nucleotide exchange factor complexes: DOCK2, DOCK8, STAC

**Reference notes:**
- DOCK2 and DOCK8 as Rho GTPase GEFs in immune cell migration
- TRPV4-Cdc42-N-wasp axis in glioblastoma invasion

## References
- [10] Notes: DOCK2 and DOCK8 as Rho GTPase GEFs in immune cell migration
- [11] Notes: Calcium channel alterations in glioblastoma stem cells and glioma tissue
- [12] Notes: NLGN4X mutations in autism; synaptic organization and neurotransmission
- [13] Notes: CNTNAP2 deficiency in ASD and neurodevelopmental disorders; role in E/I balance
- [15] Notes: ECM composition and organization profoundly influence glioma invasion patterns
- [17] Notes: IL1RAPL1 synaptic adhesion and postsynaptic density formation
- [18] Notes: ADAMTS-mediated BEHAB/brevican cleavage necessary for glioma invasion
- [19] Notes: KLF5 promotes glioblastoma angiogenesis via AGGF1
- [20] Notes: PLD1 as key player in cancer stemness and Wnt/PI3K cross-talk
- [21] Notes: TRPV4/Cdc42/N-wasp signaling axis regulates invasion-growth in glioblastoma | TRPV4 elevated in malignant glioma; TRPV4/Cdc42/N-wasp axis regulates invasion and invadopodia formation | TRPV4-Cdc42-N-wasp axis in glioblastoma invasion
- [25] Notes: OLR1 in cancer immune escape and EMT | OLR1 in immunosuppressive cell infiltration
- [27] Notes: WNT signaling roles in GSC self-renewal and glioma progression
- [30] Notes: Wnt/β-catenin pathway dysregulation in glioblastoma; correlation with WHO grade and poor prognosis
- [31] Notes: CD163 and Iba1 in TAM-mediated glioma progression | CD163, Iba1, and IL-33 in TAM-mediated glioma progression
- [32] Notes: POSTN upregulation in cancer-associated fibroblasts; promotes ECM remodeling and invasion | POSTN promotes EMT and invasion in gastric cancer; relevant to glioma microenvironment
- [34] Notes: TAM polarization and CCL8 secretion in glioma immune evasion
- [38] Notes: IGSF3 interaction with Kir4.1 and glioma-related epileptiform activity | IGSF3-Kir4.1 interaction impairs potassium buffering; dysregulation linked to glioma proliferation and seizures
- [42] Notes: CD96 immune checkpoint regulates CD8+ T-cell function and metastasis
- [45] Notes: Angiopoietin-Tie2 signaling in glioma vessel maturation
- [49] Notes: MSR1 in immune regulation and macrophage phenotype | MSR1 in macrophage-mediated immune regulation
- [50] Notes: VEGF-D role in glioblastoma angiogenesis and resistance to anti-VEGF therapy
- [54] Notes: MET-STAT4-PD-L1 axis in glioma immune evasion
- [55] Notes: RTK/Ras/PI3K pathway altered in 86-90% of GBM; critical for GBM pathogenesis
- [56] Notes: EMT and E-cadherin/N-cadherin switching in glioblastoma invasion
- [57] Notes: Hypoxia-induced HIF signaling in glioblastoma; metabolic reprogramming and GSC maintenance
- [59] Notes: EMT transcription factors and stemness maintenance in glioma
- [60] Notes: HIF-1α and HIF-2α in stemness and metabolic adaptation in glioblastoma
- [7] Notes: DOCK8 mutation impairs B-cell and T-cell immune responses relevant to glioma microenvironment
- [8] Notes: Glutamate-calcium signaling provides positive feedback for glioma progression
